Page 1 of Clinical Trials for Bortezomib, 625 Total Matches
- 1RecruitingBortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell LeukemiaLast Updated: September 21, 2011Condition(s): Plasma Cell Leukemia; Multiple Myeloma
- 2CompletedLast Updated: August 2, 2011Condition(s): Graft-versus-Host Disease
- 3Active, not recruitingLast Updated: September 1, 2011Condition(s): Prostate Cancer
- 4CompletedLast Updated: April 11, 2011Condition(s): Multiple Myeloma
- 5CompletedLast Updated: January 26, 2012Condition(s): Multiple Myeloma; Non-Hodgkin's Lymphoma
- 6Active, not recruitingLast Updated: May 4, 2012Condition(s): Multiple Myeloma
- 7Active, not recruitingLast Updated: December 20, 2007Condition(s): Multiple Myeloma
- 8RecruitingLast Updated: April 10, 2012Condition(s): Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Chronic Myelogenous Leukemia
- 9Active, not recruitingLast Updated: October 11, 2011Condition(s): Multiple Myeloma
- 10Active, not recruitingLast Updated: February 21, 2012Condition(s): Multiple Myeloma
- 11RecruitingLast Updated: April 19, 2012Condition(s): Waldenstrom's Macroglobulinemia
- 12RecruitingLast Updated: May 3, 2012Condition(s): Mantle Cell Lymphoma; Lymphoma
- 13SuspendedLast Updated: July 19, 2011Condition(s): Non Small Cell Lung Cancer
- 14CompletedLast Updated: September 28, 2010Condition(s): Acute Myelogenous Leukemia
- 15RecruitingLast Updated: May 7, 2012Condition(s): Waldenstrom's Macroglobulinemia
- 16RecruitingLast Updated: November 21, 2011Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Prolymphocytic Leukemia; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Small Intestine Lymphoma; T-cell Large Granular Lymphocyte Leukemia
- 17CompletedLast Updated: April 8, 2011Condition(s): Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
- 18RecruitingLast Updated: February 21, 2012Condition(s): Advanced Cancer
- 19RecruitingLast Updated: July 15, 2011Condition(s): Lymphoma
- 20Active, not recruitingLast Updated: March 24, 2010Condition(s): Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Bortezomib
